Feb 10, 2026 | Benefits Advisory Conference, Benefits management, Cancer, Caroline Fraker, Compliance, Forensic claims review, Gene therapy, GLP-1s, High-cost claims, MedBen University, No Surprises Act (NSA), Obesity, Orphan diseases, Pharmacy, Specialty Drugs, Stop-Loss, Transplants
Consultants and advisors from 10 different states attended the MedBen 2026 Benefits Advisory Conference on January 28. The event featured insights from some of the industry’s most respected voices and gave brokers a clearer view of today’s benefits landscape, what...
Dec 2, 2025 | Alternative Reimbursement Strategies, Cost management, Cost Savings, Direct-to-Employer Contracting, Drug costs, Fair Market Pricing, Forensic claims review, Health care costs, High-cost claims, MedBen Analytics, MedBen Rx, MedBen WellLiving, Rx Costs, Self-funding, Survey
As 2026 approaches, employers and employees alike are seeking greater stability in how they pay for health care. While national costs continue to rise, self-funding give employers a level of control over spending and plan design that traditional coverages often lack....
Sep 8, 2025 | Claims, High-cost claims, Stop-Loss
Stop-loss coverage is no longer just a safeguard – it’s essential for protecting your plan against escalating financial risk. Between 2013 and 2024, the frequency of claims exceeding $2 million grew by more than 1,250%, underscoring why having strong protection in...
Jun 17, 2025 | Claims, Client Report, Cost management, High-cost claims
Multi-million-dollar stop-loss claims have surged over the past decade, as highlighted in the Tokio Marine 2025 Annual Market Report. To help self-funded employers tackle high-dollar claims, MedBen offers a range of proven cost-management solutions. From 2019 to 2024,...
Feb 7, 2025 | Employee benefits, High-cost claims, Hospitals, Rx Costs, Survey
In a recent “Pulse of the Purchaser” employer survey, nearly three-quarters (74%) of respondents indicated that rising health care costs might force them to reconsider wage or salary increases. The same percentage also believe that rising costs will compel...
Oct 29, 2024 | Alternative Reimbursement Strategies, Chronic conditions, Client Report, Cost projections, Cost Savings, Direct-to-Employer Contracting, Drug costs, Fair market reimbursement, Forensic claims review, Health care costs, High-cost claims, MedBen Rx, MedBen WellLiving, Prescription, Rx Costs, Transparency, Trend, Wellness
Health care costs in the United States are projected to see their steepest rise in over a decade during 2025, with multiple industry analyses forecasting increases between 7% and 8% year-over-year (see table below). However, MedBen offers solutions that directly...
